These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 8168561)
1. Prevalence of hepatitis C, B and D markers in cancer patients in Turkey. Topeli A; Ozyilkan O; Ozyilkan E; Kars A; Firat D Eur J Clin Microbiol Infect Dis; 1994 Jan; 13(1):38-40. PubMed ID: 8168561 [No Abstract] [Full Text] [Related]
2. [Immunological markers in patients with a history of viral hepatitis B and D and HBsAg carriers]. Leĭbenzon AS Lik Sprava; 1995; (3-4):107-9. PubMed ID: 8819937 [No Abstract] [Full Text] [Related]
3. Sporadic acute hepatitis caused by hepatitis E virus in Egyptian adults. Gomatos PJ; Monier MK; Arthur RR; Rodier GR; el-Zimaity D; Hassan NF; Quinti I; el-Sahly AD; Sultan Y; Hyams KC Clin Infect Dis; 1996 Jul; 23(1):195-6. PubMed ID: 8816162 [No Abstract] [Full Text] [Related]
4. [The prevalence of the markers of viral hepatitis B and delta among the population in regions differing in the level of morbidity]. Iashina TL; Favorov MO; Shakhgil'dian IV; Firsova SN; Eraliev AE; Zhukova LD; Reznichenko RG Vopr Virusol; 1992; 37(4):194-6. PubMed ID: 1471341 [TBL] [Abstract][Full Text] [Related]
5. [Prevalence of serologic markers of hepatitis A, B, C, and D viruses in pregnant women]. Ortiz-Ibarra FJ; Figueroa-Damián R; Lara-Sánchez J; Arredondo-García JL; Ahued-Ahued JR Salud Publica Mex; 1996; 38(5):317-22. PubMed ID: 9092084 [TBL] [Abstract][Full Text] [Related]
6. [The markers of hepatitis B, C and D viral infection in multiply transfused patients]. Bocşan IS; Neamţu A; Rădulescu A; Rafiroiu C; Suteu O; Pascu O; Vlăduţiu D; Neamţu S; Cucuianu A; State D Bacteriol Virusol Parazitol Epidemiol; 1995; 40(2):109-13. PubMed ID: 7549251 [TBL] [Abstract][Full Text] [Related]
7. Chronic evolution of acute hepatitis B: the significance of simultaneous infections with hepatitis C and D. Copenhagen Hepatitis Acuta Programme. Krogsgaard K; Wantzin P; Mathiesen L; Ring-Larsen H Scand J Gastroenterol; 1991 Mar; 26(3):275-80. PubMed ID: 1906632 [TBL] [Abstract][Full Text] [Related]
8. [Prevalence of hepatitis B and D serological markers in the Parakanã, Apyterewa Indian Reservation, Pará State, Brazil]. Nunes HM; Monteiro MR; Soares Mdo C Cad Saude Publica; 2007 Nov; 23(11):2756-66. PubMed ID: 17952269 [TBL] [Abstract][Full Text] [Related]
9. Low prevalence of hepatitis C virus antibody in Turkish children with chronic hepatitis B infection. Ozen H; Koçak N; Yüce A; Gürakan F J Hepatol; 1995 Oct; 23(4):480. PubMed ID: 8655968 [No Abstract] [Full Text] [Related]
10. Antibodies to hepatitis C and surrogate markers in blood donors. Koerner K; Stampe D; Glück D; Kubanek B Vox Sang; 1991; 61(2):138-9. PubMed ID: 1662427 [No Abstract] [Full Text] [Related]
11. [Prevalence of markers against hepatitis B and C virus among hospital female personnel in childbearing age]. Jaqueti J; Nicolás D; Martínez Hernández D; Navarro Gallar F Aten Primaria; 1992 May; 9(8):462-3. PubMed ID: 1498244 [No Abstract] [Full Text] [Related]
12. [Seroprevalence of hepatitis C in human immunodeficiency virus infected patients]. Ranger S; Aussel L; Weinbreck P; Loustaud V; Rogues AM; Mounier M; Delpeyroux C; Denis F Pathol Biol (Paris); 1991 Feb; 39(2):126-30. PubMed ID: 1901984 [TBL] [Abstract][Full Text] [Related]
13. [Viral hepatitis: clinical interpretation of antigens and antibodies in the serum]. Páez Rodríguez O; Valdovinos Díaz MA; Wolpert E Rev Gastroenterol Mex; 1985; 50(4):277-87. PubMed ID: 2578016 [No Abstract] [Full Text] [Related]
14. A seroepidemiological survey of viral hepatitis in the Yemen Arab Republic. Scott DA; Burans JP; al-Ouzeib HD; Arunkumar BK; al-Fadeel M; Nigad YR; al-Hadad A; Elyazeed RR; Hyams KC; Woody JN Trans R Soc Trop Med Hyg; 1990; 84(2):288-91. PubMed ID: 2389323 [TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus antibodies among risk groups in Turkey. Köksal I; Biberoğlu K; Biberoğlu S; Koç F; Ayma Y; Aker F; Köksal H Infection; 1991; 19(4):228-9. PubMed ID: 1917033 [TBL] [Abstract][Full Text] [Related]
16. High prevalence of dual or triple infection of hepatitis B, C, and delta viruses among patients with chronic liver disease in Mongolia. Tsatsralt-Od B; Takahashi M; Nishizawa T; Endo K; Inoue J; Okamoto H J Med Virol; 2005 Dec; 77(4):491-9. PubMed ID: 16254981 [TBL] [Abstract][Full Text] [Related]
17. [Differential diagnosis of hepatitis A, B, C, D and E. Clinical, biochemical and virus serologic criteria. 4: Hepatitis D serology]. Eisenburg J Fortschr Med; 1995 Jan; 113(3):35-6. PubMed ID: 7890271 [No Abstract] [Full Text] [Related]
18. An outbreak of suspected water-borne epidemic non-A non-B hepatitis in northern Botswana with a high prevalence of hepatitis B carriers and hepatitis delta markers among patients. Byskov J; Wouters JS; Sathekge TJ; Swanepoel R Trans R Soc Trop Med Hyg; 1989; 83(1):110-6. PubMed ID: 2513670 [TBL] [Abstract][Full Text] [Related]
19. Prevalence of markers for hepatitis B and hepatitis D in a municipal house of correction. Barry MA; Gleavy D; Herd K; Schwingl PJ; Werner BG Am J Public Health; 1990 Apr; 80(4):471-3. PubMed ID: 2316772 [TBL] [Abstract][Full Text] [Related]
20. A study of serological markers of hepatitis B and C viruses in Istanbul, Turkey. Erden S; Büyüköztürk S; Calangu S; Yilmaz G; Palanduz S; Badur S Med Princ Pract; 2003; 12(3):184-8. PubMed ID: 12766338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]